Structure Therapeutics stockGPCR
Structure Therapeutics trades at $19.08, 79.9% below its 52-week high (Dec 8, 2025). The price is below its 50- and 200-day averages, a downtrend. −72.6% year to date, −40.8% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 18, 2026.
Ratings, candles, signals and the screener for GPCR — after you log in
Open the terminalFrequently asked questions about Structure Therapeutics
What is the Structure Therapeutics stock price?
At the close on Nov 5, 2026: $19.08 (−6.29% on the day). 52-week high: $94.90 on Dec 8, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Structure Therapeutics report earnings?
The next quarterly report is on Nov 18, 2026. Last quarter, earnings per share changed −36% year over year, revenue 0%.
Does Structure Therapeutics pay dividends?
No, Structure Therapeutics does not pay dividends.
Where does Structure Therapeutics trade and how to buy it?
Ticker GPCR, exchange Nasdaq, listed since 2023. You can buy it through a broker with access to US exchanges.
Should I buy Structure Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for GPCR are in the terminal after you log in.